Global Vaccines Innovation and Immunology Conference

Global Vaccines Innovation and Immunology Conference (Hybrid Event)September 21-23, 2026 London, UK & Online (GVX Immunology 2026)is an international platform dedicated to advancing vaccine science,strengthening immunization programs, and fostering collaboration among globalhealth leaders. This event brings together scientists, pharmaceuticaldevelopers, healthcare practitioners, biotech innovators, and policy experts toaddress the evolving challenges of vaccine development and delivery.

The 2026 conference will explore new discoveries in immunology, cutting-edgevaccine platforms, manufacturing optimization, and global preparednessstrategies. With a strong focus on innovation, Vaccine Conference 2026 willfeature sessions covering AI-supported vaccine design, genomic researchapplications, immune-response modelling, and emerging solutions forrapid-response vaccine platforms. Participants will have opportunities to joinlive keynote lectures, panel discussions, hands-on workshops, and networkingsessions.

The hybrid design ensures full accessibility, allowing participants to attendin-person in London or virtually from anywhere in the world. Virtual attendeescan access live presentations, interactive Q&A, and recorded sessions,while onsite participants can join exhibitions, roundtables, and face-to-facenetworking.

Immunology Congressalso provides a dynamic exhibition zone showcasing the latest diagnostictechnologies, vaccine-delivery devices, laboratory innovations, and biotechadvancements. By connecting global stakeholders, the conference aims toaccelerate research, support equitable vaccine access, and inspirecollaboration across sectors.

Whether you are a researcher, policymaker, industry professional, or publichealth advocate, ImmunizationConferences offers an essential opportunity to engage with leaders shapingthe future of immunization science and global health security.